Does correction of the friedewald formula using lipoprotein(a) change our estimation of ischemic heart disease risk?: The Quebec Cardiovascular Study

被引:28
作者
Cantin, B
Lamarche, B
Després, JP
Dagenais, GR
机构
[1] Univ Laval, Quebec Heart Inst, Quebec City, PQ, Canada
[2] Univ Laval, Lipid Res Ctr, Quebec City, PQ G1V 4G5, Canada
基金
加拿大健康研究院;
关键词
lipoprotein (a); LDL-cholesterol; coronary heart disease; epidemiology; population studies;
D O I
10.1016/S0021-9150(02)00034-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: LDL-cholesterol is usually calculated using the Friedewald formula. This calculation method does not take into account the presence of Lp(a), which is associated with LDL-cholesterol. Dahlen has suggested that the Friedewald formula should be modified to account for Lp(a) associated cholesterol. This study was undertaken to determine if correction of the Friedewald formula would result in a better evaluation of ischemic heart disease (IHD) risk. Methods: 2222 men free from IHD were prospectively followed for 5 years for the appearance of myocardial infarction, coronary insufficiency or coronary death. At the baseline evaluation all had a complete fasting lipid profile which included Lp(a) determinations. LDL-cholesterol levels were calculated from total cholesterol, total triglycerides and HDL-cholesterol using the Friedewald formula and also using the Dahlen modification of the Friedewald formula. Results: During the follow-up there were 89 first IHD events. Both types of LDL-cholesterol calculations showed that the last fertile of the LDL-cholesterol distribution in comparison to the first tertile, doubles the relative risk (RR: 2.15; 95% confidence limits: 1.23-3.75) using the Friedewald formula (RR: 2.18; 95% confidence limits: 1.25-3.81) using the Dahlen modification. Lp(a) levels were not an independent predictor of IHD risk. Conclusion: Modification of the Friedewald formula to account for Lp(a) levels does not improve our evaluation of IHD risk. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:261 / 267
页数:7
相关论文
共 33 条
[1]  
BERG K, 1994, CLIN GENET, V46, P57
[2]   LP(A) LEVELS IN DIFFERENT TYPES OF DYSLIPIDEMIA IN THE FRENCH POPULATION [J].
BOYER, H ;
DEGENNES, JL ;
TRUFFERT, J ;
CHATELLIER, G ;
DAIROU, F ;
BRUCKERT, E .
ATHEROSCLEROSIS, 1990, 85 (01) :61-69
[3]   SUR UN DOSAGE RAPIDE DU CHOLESTEROL LIE AUX ALPHA-LIPOPROTEINES ET AUX BETA-LIPOPROTEINES DU SERUM [J].
BURSTEIN, M ;
SAMAILLE, J .
CLINICA CHIMICA ACTA, 1960, 5 (04) :609-609
[4]   Is lipoprotein(a) an independent risk factor for ischemic heart disease in men?: The Quebec cardiovascular study [J].
Cantin, B ;
Gagnon, F ;
Moorjani, S ;
Després, JP ;
Lamarche, B ;
Lupien, PJ ;
Dagenais, GR .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (03) :519-525
[5]  
CANTIN B, 1995, AM J CARDIOL, V75, P1244
[6]  
COX DR, 1972, J R STAT SOC B, V34, P187
[7]  
CRAIG WY, 1992, CLIN CHEM, V38, P550
[8]   LIPOPROTEIN LP(A) AS PREDICTOR OF MYOCARDIAL-INFARCTION IN COMPARISON TO FIBRINOGEN - LDL CHOLESTEROL AND OTHER RISK-FACTORS - RESULTS FROM THE PROSPECTIVE GOTTINGEN RISK INCIDENCE AND PREVALENCE STUDY (GRIPS) [J].
CREMER, P ;
NAGEL, D ;
LABROT, B ;
MANN, H ;
MUCHE, R ;
ELSTER, H ;
SEIDEL, D .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1994, 24 (07) :444-453
[9]  
DAGENAIS GR, 1991, CLIN INVEST MED, V14, P93
[10]  
Dahlen G.H., 1990, LIPOPROTEINA, P151